Yolchuyeva, S.; Giacomazzi, E.; Tonneau, M.; Ebrahimpour, L.; Lamaze, F.C.; Orain, M.; Coulombe, F.; Malo, J.; Belkaid, W.; Routy, B.;
et al. A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study. Cancers 2023, 15, 3829.
https://doi.org/10.3390/cancers15153829
AMA Style
Yolchuyeva S, Giacomazzi E, Tonneau M, Ebrahimpour L, Lamaze FC, Orain M, Coulombe F, Malo J, Belkaid W, Routy B,
et al. A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study. Cancers. 2023; 15(15):3829.
https://doi.org/10.3390/cancers15153829
Chicago/Turabian Style
Yolchuyeva, Sevinj, Elena Giacomazzi, Marion Tonneau, Leyla Ebrahimpour, Fabien C. Lamaze, Michele Orain, François Coulombe, Julie Malo, Wiam Belkaid, Bertrand Routy,
and et al. 2023. "A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study" Cancers 15, no. 15: 3829.
https://doi.org/10.3390/cancers15153829
APA Style
Yolchuyeva, S., Giacomazzi, E., Tonneau, M., Ebrahimpour, L., Lamaze, F. C., Orain, M., Coulombe, F., Malo, J., Belkaid, W., Routy, B., Joubert, P., & Manem, V. S. K.
(2023). A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study. Cancers, 15(15), 3829.
https://doi.org/10.3390/cancers15153829
